Kontakt
Silcherstr 7/1
72076 Tübingen
Deutschland
2022
- M. Holl u. a., „Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM)“, Biomedicines, Bd. 10, Nr. 4, Art. Nr. 4, 2022, doi: 10.3390/biomedicines10040927.
- L. Becker u. a., „Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids“, International Journal of Molecular Sciences, Bd. 23, Nr. 13, Art. Nr. 13, 2022, doi: 10.3390/ijms23136956.
2021
- L. Becker u. a., „Raman Imaging and Fluorescence Lifetime Imaging Microscopy for Diagnosis of Cancer State and Metabolic Monitoring“, Cancers, Bd. 13, Nr. 22, Art. Nr. 22, 2021, doi: 10.3390/cancers13225682.
- M. Holl u. a., „Laparoscopic Peritoneal Wash Cytology-Derived Primary Human Mesothelial Cells for In Vitro Cell Culture and Simulation of Human Peritoneum“, Biomedicines, Bd. 9, Nr. 2, Art. Nr. 2, 2021, doi: 10.3390/biomedicines9020176.
- A. Zbinden u. a., „Collagen and Endothelial Cell Coculture Improves $\upbeta$-Cell Functionality and Rescues Pancreatic Extracellular Matrix“, Tissue Engineering Part A, Bd. 27, Nr. 13–14, Art. Nr. 13–14, Juli 2021, doi: 10.1089/ten.tea.2020.0250.
Bildungsweg
- 2019 - heute PhD Student AG Schenke-Layland, Uniklinik Tübingen
- 2016 - 2018 M. Sc. Nano-Science, Eberhard-Karls Universität Tübingen
- 2013 - 2016 B. Sc. Nano-Science, Eberhard-Karls Universität Tübingen